Top

Published in:

01-09-2020 | Laparoscopy | Original Article

Impact of surgery on quality of life in Crohn’s disease: short- and mid-term follow-up

Authors: Stefano D’Ugo, Francesca Romano, Simone Sibio, Giulia Bagaglini, Bruno Sensi, Livia Biancone, Giovanni Monteleone, Giuseppe S. Sica

Published in: Updates in Surgery | Issue 3/2020

Abstract

Active Crohn’s disease has a substantial impact on Quality of Life (QoL). Medical management could be associated to side effects, hospitalization, long treatment period and requires patient's compliance, impacting QoL. Ileocecal resection (ICR) is often required, open or laparoscopic. Aim of the study was to assess Health-Related (HR) QoL changes following ICR, and to identify factors impacting on QoL in the short and mid-term. From a single institution, we created a prospective database of patients undergoing ICR from 01/2009 to 12/2015. HRQoL was analysed with Cleveland Global Quality of Life (CGQL) score, Overall Quality of Happiness (OQH), and asking patients if they would have surgery again. QoL scores were recorded at 30 days, 6, 12 and 36 months postoperatively and compared according to follow-up timing, technique, medical treatment and demographics. Statistical analysis included 187 patients. Mean follow-up was 3.8 ± 2.9 years. Both at 30 days and 6 months postoperatively, CGQL, its items and OQH increased significantly (p < 0.001). Increased values were also recorded at 1 and 3 years; 88% of patients would undergo surgery again. Laparoscopy was associated with improved CGQL scores, while preoperative steroids with worsen data. Young female patients, with penetrating pattern, experienced greater HRQoL improvements. Surgery is associated with improvements of HRQoL and patients’ happiness in the short and mid-term. Laparoscopy, steroid-free and young patients showed the best results. ICR should be considered a reasonable alternative to non-operative strategies in selected cases.

Hovde Ø, Moum BA (2012) Epidemiology and clinical course of Crohn’s disease: results from observational studies. World J Gastroenterol 18(15):1723–1731PubMedPubMedCentral

Peyrin-Biroulet L, Cieza A, Sandborn WJ, Kostanjsek N, Kamm MA, Hibi T, Lémann M, Stucki G, Colombel JF (2010) Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis 16(1):15–22PubMed

Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ (2011) Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts. Inflamm Bowel Dis 17(1):471–478PubMed

Andersson P, Olaison G, Bodemar G, Almer S, Arvidsson M, Dabrosin-Söderholm J, Nyström PO, Smedh K, Ström M, Sjödahl R (1998) Low symptomatic load in Crohn’s disease with surgery and medicine as complementary treatments. Scand J Gastroenterol 33(4):423–429PubMed

Peyrin-Biroulet L, Cieza A, Sandborn WJ, Coenen M, Chowers Y, Hibi T, Kostanjsek N, Stucki G, Colombel JF (2012) Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 61(2):241–247PubMed

Ghosh S, Mitchell R (2007) Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 1(1):10–20PubMed

Schirbel A, Reichert A, Roll S, Baumgart DC, Büning C, Wittig B, Wiedenmann B, Dignass A, Sturm A (2010) Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 16(25):3168–3177PubMedPubMedCentral

Lesage AC, Hagège H, Tucat G, Gendre JP (2011) Results of a national survey on quality of life in inflammatory bowel diseases. Clin Res Hepatol Gastroenterol. 35(2):117–124PubMed

Iglesias M, Vázquez I, Barreiro-de Acosta M, Figueiras A, Nieto L, Piñeiro M, Gómez R, Lorenzo A, Domínguez Muñoz JE (2010) Health related quality of life in patients with Cohn’s disease in remission. Rev Esp Enferm Dig 102(11):624–630PubMed

10.

Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI (1989) Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 34(9):1379–1386PubMed

11.

Casellas F, de Acosta BM, Iglesias M, Robles V, Nos P, Aguas M, Riestra S, de Francisco R, Papo M, Borruel N (2012) Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 24(7):762–769PubMed

12.

Calvet X, Gallardo O, Coronas R, Casellas F, Montserrat A, Torrejón A, Vergara M, Campo R, Brullet E (2006) Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn’s disease. Inflamm Bowel Dis 12(8):692–696PubMed

13.

Williet N, Sandborn WJ, Peyrin-Biroulet L (2014) Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol 12(8):1246–1256PubMed

14.

Schipper H (1990) Guidelines and caveats for quality of life measurement in clinical practice and research. Oncology (Williston Park). 4(5):51–57PubMed

15.

Cross RK, Lapshin O, Finkelstein J (2008) Patient subjective assessment of drug side effects in inflammatory bowel disease. J Clin Gastroenterol 42(3):244–251PubMed

16.

Thirlby RC, Land JC, Fenster LF, Lonborg R (1998) Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg 133(8):826–832PubMed

17.

Delaney CP, Kiran RP, Senagore AJ, O’Brien-Ermlich B, Church J, Hull TL, Remzi FH, Fazio VW (2003) Quality of life improves within 30 days of surgery for Crohn’s disease. J Am Coll Surg 196(5):714–721PubMed

18.

Tillinger W, Mittermaier C, Lochs H, Moser G (1999) Health-related quality of life in patients with Crohn’s disease: influence of surgical operation—a prospective trial. Dig Dis Sci 44(5):932–938PubMed

19.

Thaler K, Dinnewitzer A, Oberwalder M, Weiss EG, Nogueras JJ, Wexner SD (2005) Assessment of long-term quality of life after laparoscopic and open surgery for Crohn’s disease. Colorectal Dis 7(4):375–381PubMed

20.

Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O’Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations. Gut 55(Suppl 1):i36–i58PubMedPubMedCentral

21.

Iaculli E, Agostini M, Biancone L, Fiorani C, Di Vizia A, Montagnese F, Sibio S, Manzelli A, Tesauro M, Rufini A, Sica GS (2016) C-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn’s disease. Cell Death Discov 2:16032. https://doi.org/10.1038/CDDiscovery.2016.32PubMedPubMedCentralCrossRef

22.

Onali S, Calabrese E, Petruzziello C, Lolli E, Ascolani M, Ruffa A, Sica G, Rossi A, Chiaramonte C, Pallone F, Biancone L (2016) Post-operative recurrence of Crohn’s disease: a prospective study at 5 years. Dig Liver Dis. 48(5):489–494PubMed

23.

Onali S, Calabrese E, Petruzziello C, Zorzi F, Sica GS, Lolli E, Ascolani M, Condino G, Pallone F, Biancone L (2010) Endoscopic vs ultrasonographic findings related to Crohn’s disease recurrence: a prospective longitudinal study at 3 years. J Crohns Colitis. 4(3):319–328PubMed

24.

Biancone L, Onali S, Calabrese E, Petruzziello C, Zorzi F, Condino G, Sica GS, Pallone F (2008) Non-invasive techniques for assessing postoperative recurrence in Crohn’s disease. Dig Liver Dis 40(2):265–270

25.

Biancone L, Sica GS, Calabrese E, Onali S, Petruzziello C, Pallone F (2008) Frequency and pattern of endoscopic recurrence in Crohn’s disease patients with ileo-colonic resection using a laparoscopic vs laparotomic approach: a prospective longitudinal study. Am J Gastroenterol 103(3):809–811PubMed

26.

Thirlby RC, Sobrino MA, Randall JB (2001) The long-term benefit of surgery on health-related quality of life in patients with inflammatory bowel disease. Arch Surg 136(5):521–527PubMed

27.

Scarpa M, Ruffolo C, D’Incà R, Filosa T, Bertin E, Ferraro S, Polese L, Martin A, Sturniolo GC, Frego M, D’Amico DF, Angriman I (2007) Health-related quality of life after ileocolonic resection for Crohn’s disease: long-term results. Inflamm Bowel Dis 13(4):462–469PubMed

28.

Haapamäki J, Turunen U, Roine RP, Färkkilä MA, Arkkila PE (2009) Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res 18(8):961–969PubMed

29.

Moskovitz DN, Maunder RG, Cohen Z, McLeod RS, MacRae H (2000) Coping behavior and social support contribute independently to quality of life after surgery for inflammatory bowel disease. Dis Colon Rectum 43(4):517–521PubMed

30.

Bullen TL, Sharpe L, Lawsin C, Patel DC, Clarke S, Bokey L (2012) Body image as a predictor of psychopathology in surgical patients with colorectal disease. J Psychosom Res 73(6):459–463PubMed

31.

Siassi M, Weiss M, Hohenberger W, Lösel F, Matzel K (2009) Personality rather than clinical variables determines quality of life after major colorectal surgery. Dis Colon Rectum 52(4):662–668PubMed

32.

Sica GS, Di Carlo S, Biancone L, Gentileschi P, Pallone F, Gaspari AL (2010) Single access laparoscopic ileocecal resection in complicated Crohn’s disease. Surg Innov. 17(4):359–360PubMed

33.

Duepree HJ, Senagore AJ, Delaney CP, Brady KM, Fazio VW (2002) Advantages of laparoscopic resection for ileocecal Crohn’s disease. Dis Colon Rectum 45(5):605–610PubMed

34.

Sica GS, Biancone L (2013) Surgery for inflammatory bowel disease in the era of laparoscopy. World J Gastroenterol 19(16):2445–2448PubMedPubMedCentral

35.

Patel SV, Patel SV, Ramagopalan SV, Ott MC (2013) Laparoscopic surgery for Crohn’s disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery. BMC Surg. 24(13):14

36.

Tabet J, Hong D, Kim CW, Wong J, Goodacre R, Anvari M (2001) Laparoscopic versus open bowel resection for Crohn’s disease. Can J Gastroenterol. 15(4):237–242PubMed

37.

Sica GS, Iaculli E, Benavoli D, Biancone L, Calabrese E, Onali S, Gaspari AL (2008) Laparoscopic versus open ileo-colonic resection in Crohn’s disease: short- and long-term results from a prospective longitudinal study. J Gastrointest Surg. 12(6):1094–1102PubMed

38.

Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, Rieder F, Almer S, Armuzzi A, Harbord M, Langhorst J, Sans M, Chowers Y, Fiorino G, Juillerat P, Mantzaris GJ, Rizzello F, Vavricka S, Gionchetti P, ECCO (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 11(1):3–25PubMed

39.

Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, Laureti S, Sampietro GM, Vucelic B, van der Woude CJ, Barreiro-de Acosta M, Maaser C, Portela F, Vavricka SR, Gomollón F, ECCO (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 2: surgical management and special situations. J Crohns Colitis. 11(2):135–149PubMed

40.

Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d’Hoore A, Pellino G, Dignass AU (2016) European Crohn’s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohns Colitis. 10(8):873–885PubMed

41.

Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G, de Buck van Overstraeten A, Burke JP, Buskens CJ, Colombo F, Dias JA, Eliakim R, Elosua T, Gecim IE, Kolacek S, Kierkus J, Kolho KL, Lefevre JH, Millan M, Panis Y, Pinkney T, Russell RK, Shwaartz C, Vaizey V, Yassin N, D’Hoore A (2018) ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 12(1):1–16PubMed

42.

Solina G, Mandalà S, La Barbera C, Mandalà V (2016) Current management of intestinal bowel disease: the role of surgery. Updates Surg. 68(1):13–23PubMed

43.

Pellino G, Keller DS, Sampietro GM, Annese V, Carvello M, Celentano V, Coco C, Colombo F, Cracco N, Di Candido F, Franceschi M, Laureti S, Mattioli G, Pio L, Sciaudone G, Sica G, Villanacci V, Zinicola R, Leone S, Danese S, Spinelli A, Delaini G, Selvaggi F, the Italian Society of Colorectal Surgery (SICCR) (2020) Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management. Tech Coloproctol 24(2):105–126

44.

Ondrula DP, Nelson RL, Pradas ML, Coyle BW, Ab-carian H (1992) Multifactorial index of preoperative risk factors in colon resections. Dis Colon Rectum 35:117–122PubMed

45.

Testini M, Margari A, Amoruso M, Lissidini G, Bonomo GM (2000) The dehiscence of colorectal anastomoses: the risk factors. Ann Ital Chir 71:433–440PubMed

46.

Furst MB, Stromberg BV, Blatchford GJ, Christensen MA, Thorson AG (1994) Colonic anastomoses: bursting strength after corticosteroid treatment. Dis Colon Rectum 37(1):12–15PubMed

47.

Gerdin L, Eriksson AS, Olaison G, Sjödahl R, Ström M, Söderholm JD, Myrelid P (2016) The Swedish Crohn Trial: a prematurely terminated randomized controlled trial of thiopurines or open surgery for primary treatment of ileocaecal Crohn’s disease. J Crohns Colitis. 10(1):50–54PubMed

48.

Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D’Haens GR, Bemelman WA, LIR!C study group (2017) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Lancet Gastroenterol Hepatol. 2(11):785–792PubMed

Title: Impact of surgery on quality of life in Crohn’s disease: short- and mid-term follow-up
Authors: Stefano D’Ugo
Francesca Romano
Simone Sibio
Giulia Bagaglini
Bruno Sensi
Livia Biancone
Giovanni Monteleone
Giuseppe S. Sica
Publication date: 01-09-2020
Publisher: Springer International Publishing
Keywords: Laparoscopy
Crohn's Disease
Published in: Updates in Surgery / Issue 3/2020
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-020-00738-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Impact of surgery on quality of life in Crohn’s disease: short- and mid-term follow-up

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2020

MRI of mucinous pancreatic cystic lesions: a new updated morphological approach for the differential diagnosis

Fluorescence-guided lymphadenectomy in gastric cancer: a prospective western series

Distal pancreatectomy with en bloc celiac axis resection for pancreatic cancer: a pooled analysis of 109 cases

Postoperative discomfort and pain in the management of hemorrhoidal disease: laser hemorrhoidoplasty, a minimal invasive treatment of symptomatic hemorrhoids

Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis

Impact of COVID-19 on thyroid cancer surgery and adjunct therapy